Central Pharmaceutical JSC No. 3 Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Dec'18

Net Sales

4,17,485.44

4,09,730.82

4,85,066.05

3,81,076.93

3,95,721.42

4,10,804.29

4,71,177.07

Other Operating Income

0.00

Total Operating income

4,17,485.44

4,09,730.82

4,85,066.05

3,81,076.93

3,95,721.42

4,10,804.29

4,71,177.07

Raw Material Cost

1,44,874.90

1,32,159.25

1,52,260.32

1,22,108.73

1,24,593.38

1,51,307.11

1,76,135.14

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

54,736.33

80,529.92

98,145.45

84,474.84

89,278.83

69,073.24

0.00

Power Cost

0.00

Manufacturing Expenses

161.50

1,594.33

733.33

449.00

1,969.22

1,165.22

1,328.83

Selling and Distribution Expenses

1,35,263.50

1,40,006.76

2,04,608.67

1,48,111.65

1,37,271.48

1,56,257.25

1,92,083.85

Other Expenses

-5,489.78

-8,212.43

-9,887.88

-8,492.38

-9,124.80

-7,023.85

-132.88

Total Expenditure (Excl Depreciation)

2,80,138.40

2,72,166.00

3,56,868.98

2,70,220.38

2,61,864.86

3,07,564.37

3,68,218.99

Operating Profit (PBDIT) excl Other Income

137347

137564.8

128197.09999999999

110856.5

133856.6

103239.9

102958.09999999999

Other Income

15,999.92

21,713.03

9,402.18

6,494.57

11,596.51

1,863.57

1,144.09

Operating Profit (PBDIT)

1,65,130.71

1,72,577.26

1,50,520.72

1,28,667.76

1,52,166.48

1,13,042.04

1,11,637.07

Interest

161.50

1,594.33

733.33

449.00

1,969.22

1,165.22

1,328.83

Exceptional Items

-605.13

0.00

Gross Profit (PBDT)

2,72,610.54

2,77,571.58

3,32,805.74

2,58,968.20

2,71,128.05

2,59,497.18

2,95,041.93

Depreciation

12,449.05

13,979.66

13,297.71

11,730.74

7,237.62

8,301.30

8,093.33

Profit Before Tax

1,51,915.02

1,57,003.26

1,36,489.68

1,16,488.02

1,42,959.63

1,03,575.52

1,02,214.91

Tax

30,743.44

31,739.89

27,665.47

23,560.97

28,899.12

20,853.74

22,151.56

Provisions and contingencies

0.00

Profit After Tax

1,21,171.58

1,25,263.37

1,03,383.00

88,280.69

1,08,357.48

76,931.25

74,458.91

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,21,171.58

1,25,263.37

1,03,383.00

88,280.69

1,08,357.48

76,931.25

74,458.91

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

1,21,171.58

1,25,263.37

1,03,383.00

88,280.69

1,08,357.48

76,931.25

74,458.91

Equity Capital

0.00

Face Value

10000.0

Reserves

5,18,880.70

4,68,472.08

4,17,449.92

3,64,872.07

3,46,448.05

3,01,686.94

1,80,861.82

Earnings per share (EPS)

5635.9

5826.22

4808.51

4106.08

5039.88

3763.81

3223.12

Diluted Earnings per share

5635.9

5826.22

4808.51

4106.08

5039.88

3763.81

3223.12

Operating Profit Margin (Excl OI)

32.74%

33.41%

26.35%

28.98%

33.69%

25.04%

21.73%

Gross Profit Margin

39.37%

41.73%

30.88%

33.65%

37.96%

27.23%

23.41%

PAT Margin

29.02%

30.57%

21.31%

23.17%

27.38%

18.73%

15.8%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2024 is 1.89% vs -15.53% in Dec 2023

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -3.27% vs 21.16% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -1.15% vs 6.91% in Dec 2023

Interest

YoY Growth in year ended Dec 2024 is -89.87% vs 117.41% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Central Pharmaceutical JSC No. 3 With

Select Peers

Figures in Million

Consolidate Annual Results

Change(VND)

Change(%)

Net Sales

4,17,485.44

23,47,221.14

-19,29,735.70

-82.21%

Other Operating Income

0.00

Total Operating income

4,17,485.44

23,47,221.14

-19,29,735.70

-82.21%

Raw Material Cost

1,44,874.90

11,43,505.83

-9,98,630.93

-87.33%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

54,736.33

4,19,680.37

-3,64,944.04

-86.96%

Power Cost

0.00

Manufacturing Expenses

161.50

5,544.68

-5,383.18

-97.09%

Selling and Distribution Expenses

1,35,263.50

8,97,260.04

-7,61,996.54

-84.92%

Other Expenses

-5,489.78

-42,522.51

37,032.73

87.09%

Total Expenditure (Excl Depreciation)

2,80,138.40

20,40,765.87

-17,60,627.47

-86.27%

Operating Profit (PBDIT) excl Other Income

1,37,347.03

306,455.27

-1,69,108.24

-55.18%

Other Income

15,999.92

23,730.07

-7,730.15

-32.58%

Operating Profit (PBDIT)

1,65,130.71

4,21,593.83

-2,56,463.12

-60.83%

Interest

161.50

5,544.68

-5,383.18

-97.09%

Exceptional Items

-605.13

0.00

-605.13

Gross Profit (PBDT)

2,72,610.54

12,03,715.31

-9,31,104.77

-77.35%

Depreciation

12,449.05

91,408.48

-78,959.43

-86.38%

Profit Before Tax

1,51,915.02

3,24,640.66

-1,72,725.64

-53.21%

Tax

30,743.44

67,282.65

-36,539.21

-54.31%

Provisions and contingencies

0.00

Profit After Tax

1,21,171.58

2,06,831.07

-85,659.49

-41.42%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,21,171.58

2,06,831.07

-85,659.49

-41.42%

Share in Profit of Associates

0.00

Minority Interest

0.00

18,340.65

-18,340.65

-100.00%

Other related items

0.00

Consolidated Net Profit

1,21,171.58

2,25,171.72

-1,04,000.14

-46.19%

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

5,18,880.70

14,19,377.49

-9,00,496.79

-63.44%

Earnings per share (EPS)

5,635.90

4,989.83

646.07

12.95%

Diluted Earnings per share

5,635.90

4,989.83

646.07

12.95%

Operating Profit Margin (Excl OI)

32.74%

13.06%

0.00

19.68%

Gross Profit Margin

39.37%

17.73%

0.00

21.64%

PAT Margin

29.02%

8.81%

0.00

20.21%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 41,748.54 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is 1.89% vs -15.53% in Dec 2023

Annual - Consolidate Net Profit

Consolidate Net Profit 12,117.16 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is -3.27% vs 21.16% in Dec 2023

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 14,913.08 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is -1.15% vs 6.91% in Dec 2023

Annual - Interest

Interest 16.15 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is -89.87% vs 117.41% in Dec 2023

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 32.74%

in Dec 2024

Figures in %

YoY Growth in year ended Dec 2024 has fallen from Dec 2023